Drreddys Laboratories reported INR154.49B in Current Liabilities for its fiscal quarter ending in September of 2026.





Current Liabilities Change Date
ANI Pharmaceuticals USD 328.72M 45.06M Sep/2026
Aurora Cannabis CAD 73.43M 6.5M Jun/2026
Bayer EUR 29.4B 2.87B Sep/2026
Canopy Growth CAD 166.75M 8.31M Jun/2026
Cipla INR 69.77B 366.6M Sep/2026
Corcept Therapeutics USD 177.68M 23.87M Sep/2026
Drreddys Laboratories INR 154.49B 13.08B Sep/2026
GlaxoSmithKline GBP 20.72B 814M Sep/2026
Hikma Pharmaceutical USD 1.45B 603M Dec/2025
Lonza CHF 3.57B 421M Dec/2025
Novartis USD 32.52B 777M Sep/2026
Pacira USD 126.1M 4.08M Sep/2026
Phibro Animal Health USD 295.79M 20.68M Sep/2026
Prestige Brands USD 168.5M 14.7M Sep/2026
Richter Gedeon HUF 212.26B 32.95B Jun/2026
Sun Pharmaceuticals INR 235.92B 9.7B Sep/2026
Supernus Pharmaceuticals USD 285.4M 61.98M Sep/2026
Teva Pharmaceutical Industries USD 15.42B 221M Sep/2026